Literature DB >> 21959107

Impact of short range hydrophobic interactions and long range electrostatic forces on the aggregation kinetics of a monoclonal antibody and a dual-variable domain immunoglobulin at low and high concentrations.

Vineet Kumar1, Nitin Dixit, Liqiang Lisa Zhou, Wolfgang Fraunhofer.   

Abstract

The purpose of this work was to determine the nature of long and short-range forces governing protein aggregation kinetics at low and high concentrations for a monoclonal antibody (IgG1) and a dual-variable-domain immunoglobulin (DVD-Ig). Protein-protein interactions (PPI) were studied under dilute conditions by utilizing the methods of static (B(22)) and dynamic light scattering (k(D)). PPI in solutions containing minimal ionic strengths were characterized to get detailed insights into the impact of ionic strength on aggregation. Microcalorimetry and susceptibility to denature at air-liquid interface were used to assess the tertiary structure and quiescent stability studies were conducted to study aggregation characteristics. Results for IgG1 showed that electrostatic interactions governed protein aggregation kinetics both under dilute and concentrated conditions (i.e., 5 mg/mL and 150 mg/mL). For DVD-Ig molecules, on the other hand, although electrostatic interactions governed protein aggregation under dilute conditions, hydrophobic forces clearly determined the kinetics at high concentrations. This manuscript shows for the first time that short-range hydrophobic interactions can outweigh electrostatic forces and play an important role in determining protein aggregation at high concentrations. Additionally, results show that although higher-order virial coefficients become significant under low ionic strength conditions, removal of added charges may be used to enhance the aggregation stability of dilute protein formulations.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21959107     DOI: 10.1016/j.ijpharm.2011.09.017

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  16 in total

1.  The limitations of an exclusively colloidal view of protein solution hydrodynamics and rheology.

Authors:  Prasad S Sarangapani; Steven D Hudson; Kalman B Migler; Jai A Pathak
Journal:  Biophys J       Date:  2013-11-19       Impact factor: 4.033

2.  Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification.

Authors:  Weixin Jin; Zizhuo Xing; Yuanli Song; Chao Huang; Xuankuo Xu; Sanchayita Ghose; Zheng Jian Li
Journal:  MAbs       Date:  2019-09-02       Impact factor: 5.857

3.  Dipole-dipole interaction in antibody solutions: correlation with viscosity behavior at high concentration.

Authors:  Shubhadra N Singh; Sandeep Yadav; Steven J Shire; Devendra S Kalonia
Journal:  Pharm Res       Date:  2014-03-18       Impact factor: 4.200

4.  Unraveling the structural basis for the unusually rich association of human leukocyte antigen DQ2.5 with class-II-associated invariant chain peptides.

Authors:  Thanh-Binh Nguyen; Priya Jayaraman; Elin Bergseng; M S Madhusudhan; Chu-Young Kim; Ludvig M Sollid
Journal:  J Biol Chem       Date:  2017-03-31       Impact factor: 5.157

5.  Charge Shielding Prevents Aggregation of Supercharged GFP Variants at High Protein Concentration.

Authors:  Joshua R Laber; Barton J Dear; Matheus L Martins; Devin E Jackson; Andrea DiVenere; Jimmy D Gollihar; Andrew D Ellington; Thomas M Truskett; Keith P Johnston; Jennifer A Maynard
Journal:  Mol Pharm       Date:  2017-09-18       Impact factor: 4.939

6.  Increased Fab thermoresistance via VH-targeted directed evolution.

Authors:  Kevin C Entzminger; Jennifer L Johnson; Jeongmin Hyun; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2015-08-16       Impact factor: 1.650

7.  Effects of ionic strength and sugars on the aggregation propensity of monoclonal antibodies: influence of colloidal and conformational stabilities.

Authors:  Shuntaro Saito; Jun Hasegawa; Naoki Kobayashi; Toshiaki Tomitsuka; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

8.  Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.

Authors:  Adriana-Michelle Wolf Pérez; Nikolai Lorenzen; Michele Vendruscolo; Pietro Sormanni
Journal:  Methods Mol Biol       Date:  2022

9.  Structure based descriptors for the estimation of colloidal interactions and protein aggregation propensities.

Authors:  Michael Brunsteiner; Michaela Flock; Bernd Nidetzky
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

Review 10.  Protein aggregation and immunogenicity of biotherapeutics.

Authors:  Ngoc B Pham; Wilson S Meng
Journal:  Int J Pharm       Date:  2020-06-09       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.